Bavarian Nordic initiates phase II PROSTVAC combo prostate cancer trial April 19, 2017 CenterWatch Staff
Ipsen appoints Dr. Alexandre Lebeaut as EVP, R&D, and chief scientific officer April 18, 2017 CenterWatch Staff
Axovant Sciences appoints Dr. David Hung CEO, Marion McCourt as president and COO April 18, 2017 CenterWatch Staff
CASI halts enrollment of ENMD-2076 triple-negative breast cancer study April 18, 2017 CenterWatch Staff
Bristol-Myers Squibb, Nordic Bioscience collaborate on fibrosis biomarker technology April 18, 2017 CenterWatch Staff
Synergy Pharmaceuticals appoints Gary G. Gemignani chief financial officer April 18, 2017 CenterWatch Staff
HitGen, Pfizer collaborate to build and screen novel DNA-encoded libraries April 18, 2017 CenterWatch Staff